M3M Foundation Boosts HPV Vaccination for Girls in Haryana's Nuh

M3M Foundation, a philanthropic arm of the M3M Group, has significantly contributed to cervical cancer prevention efforts in India by facilitating HPV vaccination for over 600 adolescent girls in the Tauru Block of Nuh district, Haryana. This initiative was carried out in close collaboration with the Health Department, Haryana, as part of an ongoing cervical cancer awareness and prevention campaign primarily targeting 14-year-old girls. The campaign successfully spanned 84 villages and 54 Gram Panchayats within the Tauru Block, including key areas such as M.P. Ahir, Rathiwas, Khori Kalan, Charora, and Padheni, among others. Cervical cancer remains a significant public health challenge in India, accounting for nearly one-fifth of the world's cervical cancer patients and approximately one in four global deaths from the disease each year. India reported an estimated 127,526 new cases and 79,906 deaths due to cervical cancer in 2022, making it the second most common cancer among women in the country. Recognizing this immense burden, the Government of India launched its first nationwide human papillomavirus (HPV) immunization campaign in March 2026, aiming to provide free vaccination to approximately 11.5 million adolescent girls, specifically those aged 14 years, who are considered to receive maximum preventive benefits before potential exposure to the virus. M3M Foundation's efforts align with this crucial national priority. The organization took a pioneering approach to health communication, becoming one of the first Corporate Social Responsibility (CSR) organizations in Haryana to develop and deploy dedicated HPV awareness Information, Education, and Communication (IEC) materials. These innovative tools, created in partnership with SYImpact Consulting, included interactive Snake & Ladder and Ludo games, flip books, quiz cards, HPV awareness songs, informative reels, and AI-powered storytelling modules. These engaging resources were designed to make discussions around preventive healthcare more accessible and appealing at the community level. Initially, the campaign faced considerable resistance stemming from misinformation, fears of adverse side effects, misleading social media narratives, and religious misconceptions surrounding HPV vaccination. However, through sustained community engagement, open dialogue, and over 90 awareness sessions conducted across more than 60 government schools, perceptions gradually shifted. These sessions successfully mobilized over 3,000 stakeholders, including school children, mothers, teachers, ASHA (Accredited Social Health Activist) workers, health officials, and community members, fostering a better understanding of the vaccine's importance. Dr. Payal Kanodia, Chairperson and Trustee, M3M Foundation, emphasized the foundation's commitment, inspired by Prime Minister Narendra Modi's vision of preventive healthcare, to ensure that girls in underserved communities receive accurate information and timely access to healthcare. Dr. Nihal Singh Solanki, Senior Medical Officer, CHC Tauru, Haryana, also acknowledged the invaluable nature of the partnership, highlighting how it strengthened acceptance of HPV vaccination and improved reach to families at the grassroots level. This initiative by M3M Foundation not only successfully surpassed its initial vaccination targets but also underscored the effectiveness of public-private partnerships in addressing critical health issues. The foundation has reiterated its commitment to continuing its collaboration with the Haryana Health Department to strengthen grassroots health systems and expand the reach of preventive care in underserved communities, thereby contributing significantly to India's fight against cervical cancer. The broader context of HPV vaccination in India is one of urgent need. Cervical cancer is preventable, yet its high mortality rate in India is exacerbated by low screening coverage and a lack of awareness. The nationwide program, alongside localized efforts like M3M Foundation's, aims to protect a generation of Indian women from this preventable disease. The HPV vaccine is proven to be highly effective, with global evidence demonstrating 93-100% effectiveness in preventing cervical cancer caused by vaccine-covered HPV types, and has an outstanding safety record with over 500 million doses administered worldwide since 2006. This combined push for vaccination and awareness is a critical step towards reducing the burden of cervical cancer in India.

Frequently Asked Questions

Read Full Story on Quick Digest